| 12/13/2024 | BKCVHY | S&P upgrades Jazz
|
| 12/11/2024 | BKCVHY | Moody’s lifts Jazz Pharmaceuticals
|
| 9/4/2024 | BKCVHY | Fitch rates Jazz notes BB
|
| 6/13/2024 | BKCVHY | S&P assigns BB- to Jazz Financing Lux loan
|
| 3/28/2024 | BKCVHY | Fitch raises Jazz
|
| 1/25/2024 | BKCVHY | Moody’s upgrades Jazz Pharmaceuticals
|
| 10/20/2023 | HY | Market Commentary: Junk: Global Aircraft needs more time; Venture better; cruisers hit headwinds, NCL at new low
|
| 10/20/2023 | HY | Market Commentary: Morning Commentary: Venture Global notes hover below issue prices; Jazz up on sale news
|
| 7/5/2023 | BKCVHY | S&P moves Jazz outlook to positive
|
| 1/20/2023 | BKCVHY | Moody's views Jazz Pharma positively
|
| 5/25/2022 | HY | Market Commentary: Buyers return to HY secondary; BB credits lifted post-Fed minutes; Frontier hits new heights
|
| 5/13/2022 | BKCVHY | Fitch revises Jazz outlook to positive
|
| 4/11/2022 | BKCVHY | Moody's turns Jazz Pharma view to stable
|
| 5/5/2021 | BKCVHY | S&P cuts Jazz Pharmaceuticals
|
| 4/23/2021 | HY | Market Commentary: Triple-hook deals in Friday junk primary; Jazz, Imperial Dade at a premium; goeasy gains
|
| 4/22/2021 | HY | Market Commentary: Four junk issuers sell $3 billion; MidCap breaks 103, Primo Water on a par-handle
|
| 4/22/2021 | CLHY | Market Commentary: Jazz, Wells Fargo, Signature, FleetCor, Parts Authority break; Resonetics changes emerge
|
| 4/22/2021 | HY | New Issue: Jazz Pharmaceuticals prices downsized $1.5 billion 4 3/8% notes due 2029 at par
|
| 4/22/2021 | HY | Jazz Pharmaceuticals talks downsized $1.5 billion eight-year secured notes at 4 5/8% area
|
| 4/21/2021 | BKCVHY | S&P rates Jazz notes BB-
|
| 4/20/2021 | HY | Market Commentary: High yield: Morgan Automotive prices; Jazz megadeal on tap; Charter flat; Emergent down again
|
| 4/20/2021 | BKCVHY | Fitch rates Jazz notes BB+
|
| 4/20/2021 | HY | Jazz Pharmaceuticals starts roadshow for $2.7 billion eight-year notes; initial talk high 4% area
|
| 4/20/2021 | BKCVHY | Moody's assigns Jazz Pharma notes Ba2
|
| 4/19/2021 | HY | Jazz Pharmaceuticals expected to bring $2.7 billion notes this week; whisper is high 4% area
|
| 4/12/2021 | CLHY | Market Commentary: ArcLight NGPL breaks; Jazz, United Airlines, UPC, GMS, Cision release price guidance
|
| 4/9/2021 | BKCVHY | Fitch assigns Jazz Pharmaceuticals BB-
|
| 4/9/2021 | CLHY | Market Commentary: Hunter Fan, Aecom, Frontier Communications, TI Group free to trade; Aptean releases talk
|
| 4/9/2021 | BKCVHY | Moody's gives Jazz Pharma facilities Ba2
|
| 4/9/2021 | BKCVHY | S&P rates Jazz loan BB-
|
| 2/4/2021 | BKHY | Jazz Pharmaceuticals gets $5.85 billion debt commitment for GW buy
|
